karbocisteiini

Karbocisteiini, also known as carbocisteine, is a mucolytic medication. It is a derivative of the amino acid cysteine and is used to treat respiratory conditions associated with excessive or viscous mucus. The primary mechanism of action for karbocisteiini is to reduce the viscosity of mucus in the airways. It achieves this by altering the structure of mucin glycoproteins, the main components of mucus. It is believed to work by breaking disulfide bonds within the mucin molecules, which leads to a less viscous and more easily cleared mucus.

Karbocisteiini is typically administered orally in the form of capsules, tablets, or syrup. It is often prescribed for conditions such as chronic bronchitis, bronchiectasis, and other respiratory diseases where mucus accumulation impairs breathing. By thinning the mucus, it facilitates expectoration, making it easier for patients to cough up phlegm. This can lead to improved breathing and a reduced risk of respiratory infections. The drug is generally well-tolerated, with common side effects including gastrointestinal disturbances such as nausea and diarrhea. It is important to consult a healthcare professional for appropriate diagnosis and treatment before using karbocisteiini.